For the past several years, life science executives and investors alike have been asking the same question: when will the capital markets fully reopen? After a challenging 2022–2023 cycle marked by inflation, rising interest rates, and geopolitical uncertainty, many hoped 2024 would bring a meaningful rebound. Instead, the year proved...Read More The post Will the Capital Markets Open in 2025 for Life Sciences? appeared first on .|
The one constant when raising financing in a life sciences company is that it takes longer than initially forecasted. As previously shared in my colleague Patrick Nugent’s article about Life Sciences Financing Trends, it is taking twice as long to close a financing round (six months or more), and the length of time...Read More The post Cash Strategies for Life Sciences Delays appeared first on .|